DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
Rudwaleit M, Listing J, Brandt J. et al.
Prediction of a major clinical response (BASDAI 50) to tumor necrosis factor α blockers in ankylosing spondylitis.
Ann Rheum Dis 2004;
63: 665-670.
We do not assume any responsibility for the contents of the web pages of other providers.